Anesthetic and physiologic effects of tiletamine, zolazepam, ketamine, and xylazine combination (TKX) in feral cats undergoing surgical sterilization.

Tiletamine (12.5 mg), zolazepam (12.5 mg), ketamine (20 mg), and xylazine (5 mg) (TKX; 0.25 ml, IM) combination was evaluated as an anesthetic in 22 male and 67 female adult feral cats undergoing sterilization at high-volume sterilization clinics. Cats were not intubated and breathed room air. Oxygen saturation (SpO(2)), mean blood pressure (MBP), heart rate (HR), respiration rate (RR), and core body temperature were recorded. Yohimbine (0.25 ml, 0.5 mg, IV) was administered at the completion of surgery. TKX produced rapid onset of lateral recumbency (4+/-1 min) and surgical anesthesia of sufficient duration to complete surgical procedures in 92% of cats. SpO(2) measured via a lingual pulse oximeter probe averaged 92+/-3% in male cats and 90+/-4% in females. SpO(2) fell below 90% at least once in most cats. MBP measured by oscillometry averaged 136+/-30 mm Hg in males and 113+/-29 mm Hg in females. MBP increased at the onset of surgical stimulation suggesting incomplete anti-nociceptive properties. HR averaged 156+/-19 bpm, and RR averaged 18+/-8 bpm. Neither parameter varied between males and females or over time. Body temperature decreased significantly over time, declining to 38.0+/-0.8 degrees C at the time of reversal in males and 36.6+/-0.8 degrees C at the time of reversal in females. Time from anesthetic reversal to sternal recumbency was prolonged (72+/-42 min). Seven cats (8%) required an additional dose of TKX to maintain an adequate plane of anesthesia at the onset of surgery, and this was associated with significantly longer recovery times (108+/-24 min).

Characteristics of free-roaming cats and their caretakers.

OBJECTIVES: To describe the characteristics of unowned, free-roaming cats and their caretakers who participated in a trap-neuter-return (TNR) program and to determine the effect of the program on free-roaming cat colonies. DESIGN: Prospective study. SAMPLE POPULATION: 101 caretakers of 920 unowned, free-roaming cats in 132 colonies in north central Florida. RESULTS: Most (85/101; 84%) caretakers were female. The median age was 45 years (range, 19 to 74 years). Most (89/101; 88%) caretakers owned pets and of those, most (67/101; 66%) owned cats. The major reasons for feeding free-roaming cats were sympathy and love of animals. Most caretakers reported that the cats they cared for were too wild to be adopted, but many also reported that they considered the cats to be like pets. The total surveyed cat population was 920 before participation in TNR and 678 after TNR. Mean colony size was 7 cats before TNR and 5.1 cats after TNR. Most cats lived on the caretaker's property. At the time of the survey, 70% (644/920) of the cats had been neutered. CONCLUSIONS AND CLINICAL RELEVANCE: The decrease in the surveyed free-roaming cat population was attributed to a reduction in births of new kittens, adoptions, deaths, and disappearances. Recognition of the human-animal bond that exists between caretakers and the feral cats they feed may facilitate the development of effective control programs for feral cat populations.

Use of the anesthetic combination of tiletamine, zolazepam, ketamine, and xylazine for neutering feral cats.

OBJECTIVE: To evaluate the use of the anesthetic combination tiletamine, zolazepam, ketamine, and xylazine (TKX) for anesthesia of feral cats at large-scale neutering clinics. DESIGN: Original study. ANIMALS: 7,502 feral cats. PROCEDURE: Cats were trapped by their caretakers for a feral cat neutering program from July 1996 to August 2000. The anesthetic combination TKX was injected IM into cats while they remained in their traps. Each milliliter of TKX contained 50 mg of tiletamine, 50 mg of zolazepam, 80 mg of ketamine, and 20 mg of xylazine. Females were spayed by veterinarians, whereas males were castrated by veterinarians or veterinary students. Yohimbine (0.5 mg, IV) was administered at the end of the procedure. Logs were kept of the individual drug doses, signalment of the cats, and any complications encountered. These data were analyzed retrospectively (1996 to 1999) and prospectively (2000). RESULTS: Of the 5,766 cats for which dosing records were complete, 4,584 (79.5%) received a single dose of TKX. The mean initial dose of TKX was 0.24 +/- 0.04 ml/cat, and the total mean dose of TKX was 0.27 +/- 0.09 ml. Overall mortality rate was 0.35% (26/7,502) cats, and the death rate attributable solely to potential anesthetic deaths was 0.23% (17/7,502) cats. CONCLUSIONS AND CLINICAL RELEVANCE: The use of TKX for large-scale feral cat neutering clinics has several benefits. The TKX combination is inexpensive, provides predictable results, can be administered quickly and easily in a small volume, and is associated with a low mortality rate in feral cats.